Welcome to
the Newsroom
Successful go-live of the Nicotinell® portfolio across Europe
Cooper Consumer Health and Dr. Reddy’s Laboratories today announced the successful go-live of the Nicotinell® nicotine-replacement therapy (NRT) portfolio across France, Spain, Portugal, Belgium and Luxembourg, with commercial operations commencing on December 1, 2025.
Successful Commercial Go-Live in Germany
Paris, France – Cooper Consumer Health is excited to announce the successful commercial launch of its operations in Germany, officially going live on January 1, 2025.
Cooper Consumer Health Partners with MagnaPharm for Distribution in Central and Eastern Europe
Paris, France – Cooper Consumer Health is pleased to announce a new strategic partnership with MagnaPharm for the distribution and commercialisation of its self-care brand portfolio in Central and Eastern Europe (CEE).
Cooper Consumer Health Completes Acquisition of Viatris Inc.’s OTC Business
Paris, France – Cooper Consumer Health is delighted to announce the successful completion of the acquisition of ’Over the Counter (OTC)’ business of Viatris Inc., a global healthcare company.
Cooper Consumer Health submits an offer to Viatris for the acquisition of Viatris’ Over-the-Counter (OTC) business
Cooper Consumer Health (“Cooper CH”) a leading European independent over-the-counter drug manufacturer and distributor, is pleased to announce today that it has submitted an offer to Viatris Inc.
Media Contact
Members of the media: please reach out to the Cooper Consumer Health media relations team here.